In vivo autoradiography of [3H]SCH 39166 in rat brain: Selective displacement by D1/D5 antagonists

Journal of Chemical Neuroanatomy

Volumn 19, Issue 1, 2000, Pages 41-46

  Duffy, Ruth A ^a   Hunt, Mary A ^b   Wamsley, James K ^c   McQuade, Robert D ^d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NEUROPSYCHIATRIC RESEARCH INSTITUTE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

Autoradiography; Dopamine D1 receptors; Mesolimbic pathway; Nigro striatal pathway; SCH 23390; SCH 39166

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; ECOPIPAM; HALOPERIDOL; KETANSERIN; BENZAZEPINE DERIVATIVE; DRD5 PROTEIN, RAT;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR OCCUPANCY; ANIMAL; BRAIN; CAUDATE NUCLEUS; DOSE RESPONSE; DRUG ANTAGONISM; METABOLISM; PUTAMEN; SPRAGUE DAWLEY RAT; SUBSTANTIA NIGRA;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; AUTORADIOGRAPHY; BENZAZEPINES; BRAIN; CAUDATE NUCLEUS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5; SUBSTANTIA NIGRA;

EID: 0034178241     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-0618(00)00045-4     Document Type: Article

References (36)

1. 3H-SCH 23390. J. Chem. Neuroanat. 5:1992;357-366.
2. Baker D.A., Fuchs R.A., Specio S.E., Khroyan T.V., Neisewander J.L. Effects of intraaccumbens administration of SCH-23390 on cocaine-induced locomotion and conditioned place preference. Synapse. 30:1998;181-193.
3. Boyson S.J., McGonigle P., Molinoff P.B. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6:1986;3177-3188.
4. Burechailo L., Martin-Iverson M.T. Behavioral sensitization to cocaine, but not cocaine-conditioned behavior, is associated with increased dopamine occupation of its receptors in the nucleus accumbens. Behav. Neurosci. 110:1996;1388-1396.
5. Caine S.B., Heinrichs S.C., Coffin V.L., Koob G.F. Effects of the dopamine D1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res. 692:1995;47-56.
6. Callahan P.M., De La Garza R. II, Cunningham K.A. Discriminative stimulus properties of cocaine: modulation by dopamine D1 receptors in the nucleus accumbens. Psychopharmacology (Berl.). 115:1994;110-114.
7. Callahan P.M., De la Garza R.E., Cunningham K.A. Mediation of the discriminitive stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacol. Biochem. Behav. 57:1997;601-607.
8. Chipkin R.E., Iorio L.C., Coffin V.C., McQuade R.D., Berger J.G., Barnett A. Pharmacological profile of SCH 39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity. J. Pharmacol. Exp. Ther. 247:1988;1093-1102.
9. De Vries T.J., Cools A.R., Shippenberg T.S. Infusion of a D1 receptor agonist into the nucleus accumbens enhances cocaine-induced behavioural sensitization. Neuroreport. 9:1998;1763-1768.
10. Grech D.M., Spealman R.D., Bergman J. Self-administration of D1 receptor agonists by squirrel monkey. Psychopharmacology (Berl.). 125:1996;97-104.
11. 3H-SCH 39166 to post mortem brain tissue. Pharmacol. Toxicol. 72:1993;152-158.
12. Halldin C., Farde L., Barnett A., Sedvall G. Synthesis of carbon-11 labelled SCH 39166, a new selective dopamine D1 receptor ligand, and preliminary PET investigations. Int. J. Radiat. Appl. Instrum. A Appl. Radiat. Isot. 42:1991;451-455.
13. Hodge C.W., Samson H.H., Chappelle A.M. Alcohol self-administration: further examination of the role of dopamine receptors in the nucleus accumbens. Alcohol. Clin. Exp. Res. 21:1997;1083-1091.
14. Levey A.I., Hersch S.M., Rye D.B. et al. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc. Natl. Acad. Sci. USA. 90:1993;8861-8865.
15. 3H]SCH 23390 in the primate cerebral cortex. Brain Res. 537:1990;349-354.
16. 3H]SCH 23390. Neuroscience. 40:1991;657-671.
17. Lidow M.S., Wang F., Cao Y., Goldman-Rakic P.S. Layer V neurons bear the majority of MRNA's encoding the five distinct dopamine receptor subtypes in the primate prefrontal cortex. Synapse. 28:1998;10-20.
18. McPherson, G.A., 1985. Kinetic, EBDA, Ligand, Lowry: a Collection Of Radioligand Binding Analysis Programs. Elsevier-Biosoft.
19. McQuade R.D., Ford D., Duffy R.A., Chipkin R.E., Iorio L.C., Barnett A. Serotonergic component of SCH 23390: in vitro and in vivo binding analyses. Life Sci. 43:1988;1861-1869.
20. McQuade R.D., Duffy R.A., Coffin V.C., Chipkin R.E., Barnett A. In vivo binding of SCH 39166: a D1 selective antagonist. J. Pharmacol. Exp. Ther. 257:1991;42-49.
21. 3H]SCH 39166, a new D1 selective radioligand: in vitro and in vivo binding analyses. J. Neurochem., 57, 2001-2009.
22. McQuade R.D., Duffy R.A., Coffin V.L., Barnett A. In vivo binding to dopamine receptors: a correlate of potential antipsychotic activity. Eur. J. Pharmacol. 215:1992;29-34.
23. Meador-Woodruff J.H., Mansour A. et al. Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology. 5:1991;231-242.
24. Meador-Woodruff J.H., Damask S.P., Wang J., Haroutunian V., Davis K.L., Watson S.J. Dopamine receptor mRNA expression in human stratum and neocortex. Neuropsychopharmacology. 15:1996;17-29.
25. Miner L.L., Drago J., Chamberlain P.M., Donovan D., Uhl G.R. Retained cocaine conditioned place preference in D1 receptor deficient mice. Neuroreport. 6:1995;2314-2316.
26. Moore R.J., Vinsant S.L., Nader M.A., Porrino L.J., Friedman D.P. Effect of cocaine self-administration on straital dopamine D1 receptors in rhesus monkeys. Synapse. 28:1998;1-9.
27. 3H]SCH 23390. Brain Res. 375:1986;291-301.
28. 11C-SCH 39166, a selective ligand for visualization of dopamine D1 receptor binding in the monkey brain using PET. Psychopharmacology. 103:1991;150-153.
29. Self D.W. Neural substrates of drug craving and relapse in drug addiction. Ann. Med. 30:1998;379-389.
30. Spealman R.D., Bergman J., Rosenzweig-Lipson S. Differential modulation of behavioral effects of cocaine by low-and high-efficacy agonists. Psychopharmacology. 133:1997;283-292.
31. Taylor L.A., Tedford C.E., McQuade R.D. The binding of SCH 39166 and SCH 23390 to 5-HT1C receptors in porcine choroid plexus. Life Sci. 49:1991;1505-1511.
32. Tedford C.E., Coffin V.L., Ruperto V. et al. Determination of plasma and brain concentrations of SCH 39166 and their correlation to conditioned avoidance behavior in rats. Psychopharmacology. 113:1993;199-204.
33. Tephly T.R., Coffman B., Styczynski P. et al. Studies of the glucuronidation of dopamine D-1 receptor antagonists, SCH 39166 and SCH 23390, by human liver microsomes. Drug Metab. Dispos. 22:1994;713-718.
34. Tice M.A.B., Hashemi T., Taylor L.A., Duffy R.A., McQuade R.D. Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes. Pharmacol. Biochem. Behav. 49:1994;567-571.
35. 3H]SCH 39166, a D1 dopamine receptor antagonist: binding characteristics and localization. Exp. Neurol. 111:1991;145-151.
36. 3H]SCH 39166. Neurochem. Int. 20(Suppl.):1992;123S-128S.